Medical abortion reporting of efficacy: the MARE guidelines

Contraception

Volumn 94, Issue 2, 2016, Pages 97-103

  Creinin, Mitchell D ^a   Chen, Melissa J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LETROZOLE; METHOTREXATE; MIFEPRISTONE; PROSTAGLANDIN DERIVATIVE; TAMOXIFEN; ABORTIVE AGENT;

COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED PRACTICE; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; LABOR INDUCTION; MEDICAL ABORTION; NOTE; PRACTICE GUIDELINE; PREGNANCY TERMINATION; INDUCED ABORTION; PROCEDURES; STANDARDS;

ABORTIFACIENT AGENTS; ABORTION, INDUCED; FEMALE; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84966747101     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2016.04.013     Document Type: Note

References (11)

1. [1] Schulz, K.F., Altman, D.G., Moher, D., for the CONSORT Group, CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. J Clin Epidemiol 63 (2010), 834–840.
2. [2] von Elm, E., Altman, D.G., Egger, M., Pocock, S.J., Gotzsche, P.C., Vandenbroucke, J.P., et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines or reporting observational studies. J Clin Epidemiol 61 (2008), 344–349.
3. [3] Creinin, M.D., Medical abortion regimens: historical context and overview. Am J Obstet Gynecol 183:2 Suppl. (2000), S3–S9.
4. [4] Borgatta, L., Kapp, N., Society of Family Planning, Clinical guidelines. Labor induction abortion in the second trimester. Contraception 84 (2011), 4–18.
5. [5] Thiersch, J.B., Therapeutic abortions with a folic acid antagonist, 4-Aminopteroyglutamic acid (4-amino P.G.A.) administered by the oral route. Am J Obstet Gynecol 63 (1952), 1298–1304.
6. [6] American College of Obstetricians and Gynecologists, Practice bulletin no. 143: medical management of first-trimester abortion. Obstet Gynecol 123 (2014), 676–692.
7. [7] Society of Family Planning, Medical management of first-trimester abortion. Contraception 89 (2014), 148–161.
8. [8] Royal College of Obstetricians and Gynaecologists, Tthe care of women requesting induced abortion. Evidence-based clinical guideline number 7, 2011, RCOG Press, London [https://www.rcog.org.uk/globalassets/documents/guidelines/abortion-guideline_web_1.pdf, Accessed December 8, 2015].
9. [9] Chen, M.J., Creinin, M.D., Mifepristone with buccal misoprostol for medical abortion: a systematic review. Obstet Gynecol 126 (2015), 12–21.
10. [10] Khan, K., The CROWN initiative: journal editors invite researchers to develop core outcomes in women's health. BJOG 121 (2014), 1181–1182.
11. [11] Williamson, P.R., Altman, D.G., Blazeby, J.M., Clarke, M., Devane, D., Gargon, E., et al. Developing core outcome sets for clinical trials: issues to consider. Trials, 13, 2012, 132.